ROLE OF 2-MICROGLOBULIN IN THE DEVELOPMENT OF CARDIORENAL SYNDROME IN COMORBID PATIENTS WITH ARTERIAL HYPERTENSION

Inna Dunaieva
DOI: https://doi.org/10.1097/01.hjh.0001020804.30923.a6
IF: 4.9
2024-05-01
Journal of Hypertension
Abstract:Objective: This study was aimed at evaluating the role of β2-M in the development of renal complications in patients with AH with type 2 diabetes mellitus. Design and method: 90 patients with AH (men/women – 48/42) and 20 control subjects were examined. All patients with AH aged 54.37±1.18. During a thorough examination and follow-up of patients, they were classified into 3 groups: patients with AH – group 1 – 31 people; group 2 – AH in combination with T2DM – 31 people; group 3 – patients with AH, T2DM, and obesity (OB) – 28 people.β2-M in the development of renal complications in patients with AH with type 2 diabetes mellitus. β2-M in the development of renal complications in patients with AH with type 2 diabetes mellitus. β2-M levels in the patients’ serum were determined by enzyme-linked immunosorbent assay using a Labline-90 analyzer (Austria) and a commercial test system manufactured by Orgentiec (ELISA, Germany) according to the instructions provided with the kit. Results: β2-M level in patients with AH was 3.09±1.08, in patients with AH and T2DM it was 3.10±0.97, in patients with AH+T2DM+obesity it was 3.14±0.84, in healthy subjects it was 1.98±0.52. p<0.001. Therefore, a significant increase (p<0.001) in the concentration of β2-M in the blood serum was noted in patients of different groups compared with the control group. An increase in β2-M concentration allowed us to confirm the presence of tubular renal dysfunction, which was not diagnosed by conventional methods. All examined patients were divided into 2 groups depending on the β2-M level (Table 1). Our data prove the role of β2-M as an independent biomarker of renal dysfunction, as well as the development of early cardiovascular complications. Conclusions: β2-microglobulin is an early independent biomarker of renal dysfunction, namely, renal tubular dysfunction in patients with hypertension and type 2 diabetes mellitus. It is advisable to determine β2-microglobulin in the diagnosis and prognosis of early manifestations of cardiorenal syndrome.
peripheral vascular disease
What problem does this paper attempt to address?